Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by David J Moliterno

51-100 of 170 results

View this query on the Wikidata Query Service
Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and [...]

scientific article (publication date: May 2007)
Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial

scientific article published in March 2017
Healing Achilles--sirolimus versus paclitaxel

scientific article published on 16 August 2005
Resistance to antiplatelet resistance is it justified?

scientific article (publication date: 7 June 2005)
A randomized two-by-two comparison of high-dose bolus tirofiban versus abciximab and unfractionated heparin versus bivalirudin during percutaneous coronary revascularization and stent placement: the tirofiban evaluation of novel dosing versus abcixi

scientific article published on January 11, 2011
Vorapaxar in patients with peripheral artery disease and acute coronary syndrome: insights from Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER).

scientific article published on 4 July 2014
Real-world bare metal stenting: identification of patients at low or very low risk of 9-month coronary revascularization

scientific article published in October 2004
Outcome of multivessel coronary intervention in the contemporary percutaneous revascularization era.

scientific article
A novel point-of-care enoxaparin monitor for use during percutaneous coronary intervention. Results of the Evaluating Enoxaparin Clotting Times (ELECT) Study

scientific article published in September 2003
Usefulness and safety of vorapaxar in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention (from the TRACER Trial).

scientific article published on 18 June 2014
Baseline NT-proBNP and biomarkers of inflammation and necrosis in patients with ST-segment elevation myocardial infarction: insights from the APEX-AMI trial

scientific article published in July 2012
Upstream use of small-molecule glycoprotein iib/iiia inhibitors in patients with non-ST-segment elevation acute coronary syndromes: a systematic overview of randomized clinical trials

scientific article published on 28 June 2011
Association of aspirin dose and vorapaxar safety and efficacy in patients with non-ST-segment elevation acute coronary syndrome (from the TRACER Trial).

scientific article published on 25 December 2013
International variation in invasive care of the elderly with acute coronary syndromes

scientific article published on 7 June 2006
The Ultegra rapid platelet-function assay: comparison to standard platelet function assays in patients undergoing percutaneous coronary intervention with abciximab therapy

scientific article published in April 2002
Vorapaxar with or without clopidogrel after non-ST-segment elevation acute coronary syndromes: results from the thrombin receptor antagonist for clinical event reduction in acute coronary syndrome trial

scientific article published on 16 September 2014
Promise of combined low-molecular-weight heparin and platelet glycoprotein IIb/IIIa inhibition: results from Platelet IIb/IIIa Antagonist for the Reduction of Acute coronary syndrome events in a Global Organization Network B (PARAGON B).

scientific article published on December 2002
Validation of BARC Bleeding Criteria in Patients With Acute Coronary Syndromes: The TRACER Trial

scientific article
Glycoprotein IIb/IIIa Receptor Inhibitors in Combination With Vorapaxar, a Platelet Thrombin Receptor Antagonist, Among Patients With Non-ST-Segment Elevation Acute Coronary Syndromes (from the TRACER Trial).

scientific article published on 18 February 2015
Second-generation drug-eluting stents and the continuous need for rapidly available real-world data

scientific article published in December 2009
The relationship of obesity to ischemic outcomes following coronary stent placement in contemporary practice

scientific article published in April 2006
Correlation of Point-of-Care ecarin clotting time versus activated clotting time with bivalirudin concentrations

scientific article published on May 1, 2003
Meta-analysis comparing reported frequency of atrial fibrillation after acute coronary syndromes in Asians versus whites

scientific article
Vorapaxar, a platelet thrombin-receptor antagonist, in medically managed patients with non-ST-segment elevation acute coronary syndrome: results from the TRACER trial

scientific article published on 13 March 2014
Triple antiplatelet therapy does not increase femoral access bleeding with vascular closure devices

scientific article (publication date: 2004)
Point-of-care ecarin clotting time versus activated clotting time in correlation with bivalirudin concentration

scientific article published in January 2004
Aspirin use post-acute coronary syndromes: intolerance, bleeding and discontinuation

scientific article (publication date: December 2003)
Safety of an abbreviated duration of dual antiplatelet therapy (≤6 months) following second-generation drug-eluting stents for coronary artery disease: A systematic review and meta-analysis of randomized trials

scientific article published on 26 August 2015
Mortality at 1 year for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularization: do tirofiban and ReoPro give similar efficacy outcomes at trial 1-year follow-up

scientific article published on 17 August 2005
Angiographic variables predict increased risk for adverse ischemic events after coronary stenting with glycoprotein IIb/IIIa inhibition: results from the TARGET trial

scientific article published in September 2003
Frequency of stent thrombosis after acute coronary syndromes (from the SYMPHONY and 2nd SYMPHONY trials)

scientific article (publication date: August 2003)
Closure devices and vascular complications among percutaneous coronary intervention patients receiving enoxaparin, glycoprotein IIb/IIIa inhibitors, and clopidogrel

scientific article (publication date: March 2005)
2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement: developed in collaboration with the American Heart Association, American Society of Echocardiography, European Association for Cardio-Thoracic Surgery, Hear

scientific article published on 19 April 2012
Clopidogrel for percutaneous coronary revascularization: time for more pretreatment, retreatment, or both?

scientific article
Six-month follow-up of patients with in-hospital thrombocytopenia during heparin-based anticoagulation (from the Complications After Thrombocytopenia Caused by Heparin [CATCH] registry).

scientific article
Peripheral vascular disease and one-year mortality following percutaneous coronary revascularization

scientific article published in September 2003
QRS duration predicts death and hospitalization among patients with atrial fibrillation irrespective of heart failure: evidence from the AFFIRM study

scientific article published on 23 December 2013
Trends in clinical trials of non-ST-segment elevation acute coronary syndromes over 15 years

scientific article published on 17 February 2012
Effects of platelet glycoprotein IIb/IIIa receptor blockers in non-ST segment elevation acute coronary syndromes: benefit and harm in different age subgroups

scientific article published on 25 October 2006
Sex-Based Differences in Cessation of Dual-Antiplatelet Therapy Following Percutaneous Coronary Intervention With Stents

scientific article published on July 2016
Heparin-induced thrombocytopenia and cardiovascular diseases

scientific article
Evaluation of a novel point-of-care enoxaparin monitor with central laboratory anti-Xa levels

scientific article published in January 2003
Effectiveness of drug-eluting stents in real-world patients

scientific article published in January 2008
Glycoprotein IIb/IIIa inhibition in early intent-to-stent treatment of acute coronary syndromes: EPISTENT, ADMIRAL, CADILLAC, and TARGET.

scientific article
Sudden Cardiac Death After Non-ST-Segment Elevation Acute Coronary Syndrome

scientific article published on April 2016
Glycoprotein IIb/IIIa antagonism and fibrinolytic therapy for acute myocardial infarction

scientific article (publication date: April 2002)
Sex-Stratified Trends in Enrollment, Patient Characteristics, Treatment, and Outcomes Among Non-ST-Segment Elevation Acute Coronary Syndrome Patients: Insights From Clinical Trials Over 17 Years

scientific article published on 7 July 2015
An automated strategy for bedside aPTT determination and unfractionated heparin infusion adjustment in acute coronary syndromes: insights from PARAGON A.

scientific article published in August 2002
Low-molecular-weight heparin therapy for non-ST-elevation acute coronary syndromes and during percutaneous coronary intervention: an expert consensus

scientific article
Arterial access site and outcomes in patients undergoing percutaneous coronary intervention with and without vorapaxar

scientific article published on 23 December 2015

Paulina is supported by:

About Paulina

Help